These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
616 related items for PubMed ID: 6819611
1. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974]. Augé C, Lecocguic Y, Touaty E, Bussi S, Pariente R. Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611 [No Abstract] [Full Text] [Related]
7. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM, Goldberg SV. Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [Abstract] [Full Text] [Related]
8. [Cooperative study of short-term antibacillary treatments in 14 French centers]. Brouet G. Bull Int Union Tuberc; 1974 Nov; 49(1):398-410. PubMed ID: 4219734 [No Abstract] [Full Text] [Related]
9. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group. Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516 [Abstract] [Full Text] [Related]
15. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections. Vall-Spinosa A, Lester W, Moulding T, Davidson PT, McClatchy JK. N Engl J Med; 1970 Sep 17; 283(12):616-21. PubMed ID: 4988918 [No Abstract] [Full Text] [Related]
16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK, Kim JH, Kang H, Cho JS, Smego RA. Int J Infect Dis; 2009 Mar 17; 13(2):170-5. PubMed ID: 18768342 [Abstract] [Full Text] [Related]